Navigation Links
First compound that specifically kills cancer stem cells found
Date:8/13/2009

The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.

"It wasn't clear it would be possible to find compounds that selectively kill cancer stem cells," said Piyush Gupta of the Massachusetts Institute of Technology (MIT) and the Broad Institute. "We've shown it can be done."

The team including MIT's Robert Weinberg and the Broad Institute's Eric Lander developed a new high-throughput screening method that makes it possible for the first time to systematically look for agents that kill cancer stem cells. That ability had previously eluded researchers due to the rarity of those cells within tumor cell populations and their relative instability in laboratory culture.

In the new study, the researchers manipulated cultured breast cancer cells to greatly enrich for those with the stem-like properties, including increased resistance to standard cancer drugs. They then screened a library of 16,000 natural and commercial chemical compounds for their ability to kill those stem-like cells and not other cancer cells. That screen turned up 32 contenders.

The researchers narrowed that list down to a handful of chemicals that they could readily get in sufficient quantities for further testing on normal cancer stem cells. Of those, one called salinomycin was the clear winner.

Salinomycin reduced the proportion of breast cancer stem cells by more than 100-fold compared to a commonly used chemotherapeutic drug for breast cancer called paclitaxel (aka Taxol). Salinomycin-treated cells were less able than paclitaxel-treated ones to seed tumors when injected into mice, they report. Salinomycin treatment also slowed the growth of the animals' tumors.

Studies of
'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Page: 1 2

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...PRNewswire/ -- Menopause - it,s an unavoidable par...f uncomfortable symptoms that negatively impact qu...s, weight gain , night sweats and lethargy are ju... and perimenopause. What,s worse, menopause signs... actual menopause occurs (perimenopause), and can ...
(Date:11/30/2009)...Uses Tent To Simulate High Altitude, Low O2 Condit...wire/ -- Distance runners who live at high altitud...ir performance during races in areas that are at s... from fatigue, improve their exercise performance ...? ,, That is the question being studied among 1...
(Date:11/30/2009)...PRNewswire/ -- The launch of Invivo Corporation,s ...rst FDA-cleared, fully-automated morphological sys...t of suspicious breast lesions. The ONCAD system w...iety of North America 2009 Annual Meeting in Chica...perts in breast MRI, ONCAD for DynaCAD uses a pate...
(Date:11/30/2009)...results in animals , , MONDAY, Nov. 30...ggest that stem cells from transplanted human-deri...g and heart disorders. , Scientists already kn...ong list of different kinds of cells in the labora...ter in Seoul, Korea, co-author of one of the studi...
(Date:11/30/2009)...ire/ --- Salon Leau announced today they are hosti... raise funds and create positive impact in the fig...ds from each haircut and or color will be donated ...alon Leau has been serving the posh Washington DC ...widely recognized for her innovation in color, cut...
Breaking Medicine News(10 mins):Health News:Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2
... Insurance Coverage Exclusions for,Pre-existing Co..., WASHINGTON, Oct. 26 The National Patient,Advoc...ganization dedicated,to the mission of creating av...(D-WV) for acting to protect Americans at,risk of ...
...iental,Bioengineering, Inc. (NYSE: AOB ), a leadi...rmaceutical and nutraceutical products in China, t...l investor conferences in,November. The Company w...nagement is currently scheduled to present at,1:55...
...d Companies Control Health Care Costs, DALLAS, Oc...cs" Kenneth H. Cooper, M.D., M.P.H., Cooper Aerobi...r acquisition in the company,s 37-year,history. Co...Benefits merges traditional employee benefits cons...
...n Jack Group, Inc.,(MattsonJack) announces the rel... Database(TM) is designed to help clients make str...g of the importance of mutually,exclusive and over...nd Comorbidity Database(TM) -- Med 2.0, which feat...
...Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the...nced that data from a 12-month study of DAYTRANATM...on Deficit Hyperactivity Disorder (ADHD) patch, de...esented today at a major scientific and educationa...
...ty is a societal problem that needs to be solved. ...patitis or NASH, is just one of the many complicat...or NASH are limited, and therefore there is an unm...ing hand to potentially aid in abolishing the occu...
Other Medicine News:Health News:National Patient Advocate Foundation Hails Senator Rockefeller for Introducing Bill Protecting Patient Access to Health Coverage 2Health News:American Oriental Bioengineering Announces Participation in November Healthcare Conferences 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 3Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 4Health News:The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM) 2Health News:Long-term 12-month safety data on ADHD patch DAYTRANA 2Health News:Attenuation of NASH by stimulation of free fatty acid metabolism 2
(Date:11/30/2009)...PRNewswire-FirstCall/ -- NightHawk Radiology Servi...o radiology groups and hospitals throughout the Un...Assurance (QA) program to foster better communicat... and to deliver superior patient care. ,, Nig... program in several presentations at RSNA 2009. Ni...
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Surgical Incision Closures - Global Trends ...al-Incision-Closures---Global-Trends.html ,, S...gnificance, due to the millions of surgical proced...es such as cardiology, obstetrics/gynecology, orth...
(Date:11/30/2009)...RNewswire/ -- Cytokine PharmaSciences, Inc. today ...I-2364, its orally active, small-molecule inhibito...lammatory cytokines. Results of the safety and to...eers confirm the safety of this compound in initia...ts completed the study, including those receiving ...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Young leukemia and lymphoma patients live longer today than in years past 55090 1Young leukemia and lymphoma patients live longer today than in years past 55090 2The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 1The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 2U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 1U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 2
...l 2 Novo Nordisk today announced that the Endocri...the United States Food and Drug Administration (FD...ted to liraglutide, a once-daily human GLP-1 analo...ns related to the risk profile of liraglutide. , ...bers supported that appropriate evidence of cardio...
...2 Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Co...e discovery and development of novel antibiotics f...s, today announced that its lead compound, delaflo...tors for the 8th annual report on "100 Great Inves...ue. , , R&D Directions is a leading pharmaceu...
Other Medicine Technology:Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 2Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 3Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 4
Rutner Universal Wedge Ureteral Catheter
...njection of contrast medium, anesthetic gel, and/o...minates the need for multiple catheterizations. Th...atic passage into and through the ureter. AQ is a ...ctivated, attracts and holds water and other liqui...
Whistle-tip Ureteral Catheters (Left Ureter)
Whistle-tip
Medicine Products: